Table 1.
Baseline Patient Characteristics Between Two Cohorts
| Characteristics | Pre–COVID-19 Cohort (N=6) |
COVID-19 Cohort (N=30) |
P Value |
|---|---|---|---|
| Age, median (IQR) | 60.3 (17.3) | 62.6 (26.1) | 0.92 |
|
Race, no. (%)
Black White Other/Unknown |
4 (66.7) 1 (16.7) 1 (16.7) |
18 (60.0) 6 (20.0) 6 (20.0) |
1.0 |
| Females, no. (%) | 3 (50.0) | 17 (56.7) | 1.0 |
| Expired, no. (%) | 2 (33.3) | 16 (53.3) | 0.66 |
| Sepsis as primary cause of death, no. (%) | 2 (100.0) | 6 (37.5) | 0.18 |
|
Charlson comorbidity index, no. (%) 0–1 2–3 4–5 >5 |
1 (16.7) 3 (50.0) 1 (16.7) 1 (16.7) |
9 (30.0) 7 (23.3) 4 (13.3) 10 (33.3) |
0.64 |
|
Type of central venous catheter
a, no. (%) Peripherally inserted central venous catheter Internal jugular Mediport Femoral Subclavian |
2 (33.3) 4 (66.7) 0 (0.0) 0 (0.0) 0 (0.0) |
5 (15.6) 13 (40.6) 1 (3.1) 7 (21.9) 6 (18.8) |
0.48 |
|
Central venous catheter insertion location, no. (%) Emergency department Floor (acute care or intensive care unit) Interventional radiology or operating room Present on admission |
0 (0.0) 4 (66.7) 2 (33.3) 0 (0.0) |
4 (13.3) 14 (46.7) 11 (36.7) 1 (3.3) |
0.87 |
| Intensive care unit, no. (%) | 3 (50.0) | 21 (70.0) | 0.38 |
| Vasopressors, no. (%) | 3 (50.0) | 22 (73.3) | 0.34 |
| Ventilator, no. (%) | 2 (33.3) | 21 (70.0) | 0.16 |
| Bilevel positive air pressure, no. (%) | 2 (33.3) | 4 (13.3) | 0.26 |
| Length of stay, median (IQR) | 19.0 (9.0) | 27.0 (33.0) | 0.12 |
| Causative organism from blood culture associated with CLABSI, no. (%) | 0.22 | ||
| Fungal Gram negative Gram positive |
4 (66.7) 0 (0.0) 2 (33.3) |
8 (26.7) 6 (20.0) 16 (53.3) |
|
Note. COVID-19, coronavirus 2019; IQR, interquartile range; CLABSI, central-line–associated bloodstream infection.
a
2 patients had multiple central venous catheters.